Old Web
English
Sign In
Acemap
>
Paper
>
Efficacy and Safety of Biosimilar Infliximab in Bio-naïve Patients With Crohn’s Disease
Efficacy and Safety of Biosimilar Infliximab in Bio-naïve Patients With Crohn’s Disease
2021
Oike T
Naoki Akizue
Yuki Ohta
H. Koseki
Saito M
Nagashima A
Ishikawa T
Shiratori W
Kaneko T
Tokunaga M
Oura H
Yuya Yokoyama
Yushi Imai
Kanayama K
Takashi Taida
Kenichiro Okimoto
Keiko Saito
Sadahisa Ogasawara
Tomoaki Matsumura
T. Nakagawa
Arai M
Tatsuro Katsuno
Fukuda Y
Kitsukawa Y
Kato J
Kato N
Keywords:
Internal medicine
therapy naive
Infliximab
Biosimilar
Crohn's disease
Medicine
Correction
Source
Cite
Save
Machine Reading By IdeaReader
0
References
0
Citations
NaN
KQI
[]